India Dexamethasone and Betamethasone

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 20, 2018

Primary Completion Date

February 28, 2019

Study Completion Date

December 31, 2019

Conditions
Preterm BirthAntenatal Corticosteroids
Interventions
DRUG

Dexamethasone 4 mg/ml

Intramuscular. Total dose: 1.5 mL (6 mg)

DRUG

Betamethasone 4 mg/ml

Intramuscular. Total dose: 1.5 mL (6 mg)

DRUG

Celestone Soluspan 6Mg/Ml Suspension for Injection

Intramuscular. Total dose: 1 mL (6 mg)

DRUG

Dexamethasone Oral Tablet

Oral. Total dose: 12 Tablets (6 mg)

DRUG

Betamethasone Oral Tablet

Oral. Total dose: 12 Tablets (6 mg)

Trial Locations (1)

560 100

Syngene International Limited, Tower I, Bangalore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bill and Melinda Gates Foundation

OTHER

collaborator

Syngene

INDUSTRY

lead

Children's Hospital Medical Center, Cincinnati

OTHER